HYPR
Hyperfine, Inc. Healthcare Medical Devices
8/12
Innovation Score
Patent Activity
1/3
1 patent found
OK_NORMALIZED
Cash Runway
1/3
18 months of cash remaining based on current burn rate.
Cash on hand: $40.8M
Cash on hand: $40.8M
Revenue Trajectory
3/3
Revenue: $15.3M
YoY Growth: +82.6%
YoY Growth: +82.6%
Management Quality
3/3
Insider ownership: 12.5%
SBC/Revenue: 46.1%
No reverse splits detected
SBC/Revenue: 46.1%
No reverse splits detected
Key Metrics
Market Cap
$101.3M
Revenue
$15.3M
Revenue Growth (YoY)
+82.6%
Cash on Hand
$40.8M
Cash Runway
18 months
Shares Outstanding
91.0M
Insider Ownership
12.5%
SBC / Revenue
46.1%
Sector / Industry
Healthcare / Medical Devices
Patents (1)
Match type: OK_NORMALIZED
- Suppressing image artifact with RF pulse phase in multi-shot SS-FSE sequence
7-Step Risk Assessment
How HYPR maps to our micro cap methodology:
- Innovation Signal 1 patent identified. This suggests the company is investing in defensible IP.
- Cash Runway Check 18 months of runway. Short runway increases dilution risk — watch for capital raises.
- Revenue Trajectory +82.6% YoY growth on $15.3M revenue. Strong growth trajectory.
- Management Alignment Insiders hold 12.5% of shares. SBC is 46.1% of revenue.
- Competitive Moat Review the company's 10-K for barriers to entry: patents, network effects, switching costs, regulatory approvals. This step requires manual research.
- Catalyst Identification Look for upcoming catalysts: FDA decisions, contract wins, product launches, partnerships. Check recent 8-K filings and earnings transcripts.
- Position Sizing Micro caps carry outsized risk. Consider position sizing relative to conviction level and portfolio concentration. This is a $101.3M company.
Financial Detail
Free Cash Flow
$-16.8M
FCF Yield
-16.6%
Return on Equity
-89.8%
Debt / Equity
38.9%
Gross Margin
51.2%
Profit Margin
-226.9%
Operating Margin
-219.3%
Price / Book
2.74
Current Ratio
5.52
Dividend Yield
None
Share Count Change (YoY)
N/A
Share Count Change (3yr)
N/A
Quality Flags
Low Debt
Free Cash Flow Trend
Insufficient Data
Consecutive Years FCF Positive
0
Disclaimer: This is an automated screening tool, not investment advice. Micro cap stocks are inherently risky with low liquidity and high volatility. The innovation score is based on publicly available data and may not reflect the full picture. Steps 5-7 of the methodology require your own research. See our full disclaimer.
Last screened: 2026-08-08